Skip to main content
Fig. 6 | Biomarker Research

Fig. 6

From: Long non-coding RNA SLC25A21-AS1 inhibits the development of epithelial ovarian cancer by specifically inducing PTBP3 degradation

Fig. 6

PTBP3 can reverse the inhibitory effect of SLC25A21-AS1 on EOC cells. a PTBP3 rescued the inhibitory effect of SLC25A21-AS1 on EOC cells proliferation (n=3). b Overexpression of both SLC25A21-AS1 and PTBP3 reduced the apoptosis of EOC cells compared with the SLC25A21-AS1 group**P<0.01. c The addition of PTBP3 with SLC25A21-AS1 re-increased the percentage of ovarian cancer cells in G2 phase. d PTBP3 effectively rescued the inhibitory migration and invasion effects of SLC25A21-AS1 (n=3). e EdU assay to detect the role of SLC25A21-AS1 and PTBP3 in ovarian cancer cell proliferation. Error Bars represent the mean ± SD of three independent replicate experiments. ***P<0.001, **P<0.01

Back to article page

Biomarker Research

ISSN: 2050-7771

Contact us